Abbott Laboratories (ABT) Azione Prezzo
Abbott Laboratories Prezzo
Negli ultimi 19 anni Abbott Laboratories ha aumentato il fatturato del 3,6% all'anno, raggiungendo 44,33 miliardi USD. L'utile per azione è cresciuto del 6,6% all'anno negli ultimi 19 anni. Per Abbott Laboratories, il margine netto del 14,7% risulta in calo rispetto al 16,4% di alcuni anni fa. Al prezzo attuale il rendimento da dividendo è pari a circa il 2,26%. Il payout ratio è pari a circa il 63% degli utili. Il dividendo è cresciuto del 3,8% all'anno negli ultimi 19 anni. Il target di prezzo di consenso a 12 mesi per Abbott Laboratories è 121,00 USD, circa il 16,0% sopra il prezzo attuale di mercato. Su 32 analisti, 26 valutano il titolo come acquisto — nel complesso un consenso Acquistare.
Abbott Laboratories Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Abbott Laboratories Azione e analisi azionaria
Domande frequenti sull'azione Abbott Laboratories
Abbott Laboratories is a renowned healthcare company with a strong business model focused on providing a diverse range of medical products, diagnostics, nutritional supplements, and pharmaceuticals. By combining technological advancements with innovative research, Abbott aims to enhance the quality of life for individuals worldwide. With a comprehensive portfolio spanning diverse healthcare sectors, including diagnostics, nutrition, diabetes care, medical devices, and branded generic pharmaceuticals, Abbott Laboratories strives to improve patient outcomes and deliver sustainable growth. Through its commitment to scientific excellence and dedication to meeting evolving healthcare needs, Abbott Laboratories has established itself as a trusted leader in the global healthcare industry.
Abbott Laboratories is primarily active in the healthcare industry.
The main competitors of Abbott Laboratories in the market are Johnson & Johnson, Pfizer, and Roche Holding AG.
Abbott Laboratories is a renowned American healthcare company, known for providing a diverse range of medical, pharmaceutical, and nutritional products. Founded in 1888 by Dr. Wallace C. Abbott, the company initially focused on producing pharmaceuticals, including the widely successful alkaloid-based pain reliever, Abbott's ABC Liniment. Over the years, Abbott Laboratories has expanded its portfolio, venturing into areas such as diagnostics, medical devices, and nutrition. The company's commitment to innovation is evident through breakthroughs like the development of the first HIV blood-screening test. Today, Abbott Laboratories continues to play a crucial role in improving health outcomes worldwide, with its cutting-edge technology and a focus on delivering quality healthcare solutions.
Abbott Laboratories has achieved several significant milestones throughout its history. One major milestone was the development and commercialization of the first-ever HIV blood screening test, which greatly contributed to safer transfusions and the prevention of the spread of HIV. Additionally, Abbott Laboratories introduced breakthrough medical devices, such as the FreeStyle® Libre system, a continuous glucose monitoring system for diabetes management. The company also played a crucial role in the fight against COVID-19 by developing rapid diagnostic tests for the virus. Furthermore, Abbott Laboratories has consistently been recognized for its commitment to innovation and sustainability, making it a leading healthcare company globally.
Abbott Laboratories is primarily present in multiple countries and regions worldwide. The company operates in more than 160 countries, including the United States, Canada, Europe, Asia-Pacific, Latin America, and the Middle East. With a strong global footprint, Abbott Laboratories has established itself as a leading healthcare company in various markets, delivering innovative medical products, diagnostics, nutritionals, and pharmaceuticals to improve people's health and well-being.
Abbott Laboratories is committed to its core values of putting patients first, serving customers with innovative solutions, and operating with integrity in all aspects of its business. The company's corporate philosophy centers around improving life through the development of groundbreaking technologies and products. Abbott Laboratories prides itself on its dedication to delivering reliable healthcare solutions, fostering collaboration with healthcare professionals, and investing in research and development to address unmet medical needs. With a focus on providing high-quality and accessible healthcare options, Abbott Laboratories strives to create positive impacts in communities worldwide through its diverse portfolio of medical devices, diagnostics, nutrition, and pharmaceutical products.
Gli analisti fissano attualmente un prezzo obiettivo medio di 123,64 USD per l’azione Abbott Laboratories (mediana: 121,00 USD), pari a +18,5 % rispetto all’ultimo prezzo. Il consenso si basa su 32 giudizi di analisti.
32 analisti valutano attualmente l’azione Abbott Laboratories: 26 raccomandano l’acquisto, 6 la tenuta e 0 la vendita. Per il 2026 gli analisti si aspettano per Abbott Laboratories ricavi pari a 50,30 miliardi USD e un utile per azione di 5,52 USD.
Convertita al tasso di cambio attuale, l’azione Abbott Laboratories quota 93,25 EUR (104,31 USD).
L’azione Abbott Laboratories (ABT) è quotata su 9 borse, tra cui: NYSE (ABT), London (0Q15.L), SIX (Zürich) (ABT.SW), XETRA (ABL.DE), Frankfurt (ABL.F), München (ABL.MU), Düsseldorf (ABL.DU), Hamburg (ABL.HM).
Abbott Laboratories is a global company specializing in the development, manufacturing, and marketing of health products and services. Its business model is divided into different divisions that focus on the needs of patients, doctors, and healthcare systems. The divisions of Abbott Laboratories include Diagnostics, Medical Devices, Nutrition, and Pharmaceutical. The company aims to continuously develop innovative technologies and products to improve healthcare, and it offers a wide range of services and support programs for patients. Abbott Laboratories has established a strong market position and global presence in over 160 countries since its establishment in 1888. It also pursues a successful acquisition strategy to expand its product portfolio, such as the acquisition of St. Jude Medical in 2017 to enhance its cardiovascular products and services. Overall, Abbott Laboratories aims to improve healthcare and meet the needs of patients, doctors, and healthcare systems through its comprehensive strategy focused on developing innovative products, expanding into new markets, and increasing efficiency.
Il attesa fatturato di Abbott Laboratories ammonta a 50,30 miliardi USD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il attesa profitto di Abbott Laboratories ammonta a 9,64 miliardi USD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Abbott Laboratories è attualmente 18,90. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Abbott Laboratories.
Il rapporto prezzo/fatturato (P/S) di Abbott Laboratories è attualmente 3,62. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Abbott Laboratories.
Il Quality Score AlleAktien per Abbott Laboratories è 6/10.
L'ISIN di Abbott Laboratories è US0028241000. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Abbott Laboratories è 850103. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Abbott Laboratories è ABT. Con questo simbolo di borsa vengono negoziate le azioni Abbott Laboratories in borsa.
Azione Abbott Laboratories
Gruppo di pari di Abbott Laboratories
Abbott Laboratories Ticker
Abbott Laboratories FIGI
Altre metriche e analisi di Abbott Laboratories in Deep Dive.
La nostra analisi azionaria dell'azione Abbott Laboratories include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Abbott Laboratories. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: